Entry Detail



General Information

Database ID:exR0080594
RNA Name:RPL3
RNA Type:mRNA
Chromosome:chr22
Starnd:-
Coordinate:
Start Site(bp):39312882End Site(bp):39320389
External Links:ENSG00000100316



Disease Information

Disease Name:Fragile X Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D005600
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Fragile X Syndromes//Syndrome, Fragile X//Syndromes, Fragile X//Marker X Syndrome//Marker X Syndromes//Syndrome, Marker X//Syndromes, Marker X//Mental Retardation, X-Linked, Associated With Marxq28//X-Linked Mental Retardation and Macroorchidism//X Linked Mental Retardation and Macroorchidism//Fragile X Mental Retardation Syndrome//Martin-Bell Syndrome//Martin Bell Syndrome//Syndrome, Martin-Bell//Fra(X) Syndrome//FRAXE Syndrome//FRAXE Syndromes//Syndrome, FRAXE//Syndromes, FRAXE//Mental Retardation, X-Linked, Associated With Fragile Site Fraxe//Fragile X-F Mental Retardation Syndrome//Mar (X) Syndrome//FRAXA Syndrome//FRAXA Syndromes//Syndrome, FRAXA//Syndromes, FRAXA



Expression Detail

GEO ID:GSE83556
Description:Global transcriptome dysregulation in second trimester fetuses with FMR1 expansions
Experimental Design:Disease vs Control
Case Disease Type:Fragile X Syndrome
Case Disease SubType:NA
Case Sample:Fragile X Syndrome
Control Sample:Normal
Number of Case:22
Number of Control:18
Number of Samples:40





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ABLIM1
chr10
114431113
114768061
-
AC046185.1
chr17
63702845
63752097
-
ACSS1
chr20
25006230
25058980
-
AIF1L
chr9
131096476
131123152
+
AC105052.3
chr7
102637049
102671641
-
AKAP11
chr13
42272152
42323261
+
AHCYL1
chr1
109984765
110023742
+
ADK
chr10
74151202
74709963
+
ADORA2A
chr22
24417879
24442357
+
ADCY5
chr3
123282296
123449758
-
ALDOA
chr16
30064164
30070457
+
ADAMTS19
chr5
129460281
129738683
+
AC012254.2
chr18
47108188
47176345
-
ADGRG5
chr16
57542643
57591681
+
AC023055.1
chr12
55757275
55827546
-
AC002985.1
chr19
18907013
18934397
-
AC073508.2
chr17
40627356
40665141
-
AC011448.1
chr19
19516227
19536076
+
AFG3L2
chr18
12328944
12377227
-
ADD1
chr4
2843857
2930076
+
AC018523.2
chr11
14493783
14520344
-
AGBL3
chr7
134986508
135147963
+
AC010422.3
chr19
12643831
12648397
-
ACO2
chr22
41469117
41528989
+
AKR1B1
chr7
134442356
134459284
-
AL136454.1
chr1
192716132
192716653
+
AC129492.3
chr17
8150816
8162975
-
AASDHPPT
chr11
106075501
106098699
+
ACTG1
chr17
81509971
81523847
-
AARSD1
chr17
42950526
42964498
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-3654
chr7
133034860
133034878
-
hsa-miR-4426
chr1
192716333
192716349
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC004687.1
chr17
58330884
58332508
-
AC005899.4
chr17
32328441
32329395
+
AC007780.1
chr17
68413623
68524949
+
AC007952.4
chr17
19112000
19112636
-
AC021078.1
chr5
149494314
149504670
-
AC022211.4
chr17
75138416
75141350
-
AC023509.1
chr12
53441741
53467528
+
AC026362.1
chr12
122975320
122982907
+
AC026979.2
chr8
30155830
30156232
-
AC091564.7
chr11
6610883
6616594
-
AC109460.3
chr16
28974804
28990775
+
AC113189.2
chr17
7420103
7444081
+
AC113189.4
chr17
7439506
7445966
+
AC115284.1
chr3
51961212
51974031
-
AC132217.1
chr11
2129121
2129964
-
AC239868.1
chr1
149861271
149862504
+
AC245014.3
chr1
145281116
145281462
+
AD000090.1
chr19
35557956
35581954
+
AL022311.1
chr22
37876148
37895563
+
AL136419.1
chr14
23969931
24051377
+
Display:



Experiment Detail

GEO ID:GSE83556
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:RNA was extracted from 5-15 mL amniotic fluid supernatant (centrifugation at 350g, 4C, 10, min).
RNA Extract protocol:All samples were processed using the Qiagen Circulating Nucleic Acid kit with an on-column DNase digestion step to remove genomic DNA. The RNA was then purified and concentrated with the RNeasy MinElute Clean up kit and eluted in RNasefree water.
RNA library preparation protocol:RNA was converted to cDNA and amplified using the Ovation Pico WTA kit V2 and then purified with the QIAquick PCR Purification kit. Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA)Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA).



Reference

PMID:NA
Title:NA
Author:NA
Journal:NA
Description:NA